• Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous; Note=2 out of 3 copies (PubMed=16364757).
  

PubMed=11062710
Bar J.K., Harlozinska-Szmyrka A.U.
Morphological and phenotypic characterization of a new established ovarian carcinoma cell line (OvBH-1).
Anticancer Res. 20:2975-2980(2000)

CLPUB00470
Bar J.K., Harlozinska-Szmyrka A.U., Wyrodek E., Kartarius S., Montenarh M., Rodriguez-Parkitna J.M., Kochman M., Ozyhar A.
A characterization of the temperature-sensitivity of an ovarian carcinoma cell line (OvBH-1), independent of p53 status.
Cell. Mol. Biol. Lett. 7 Suppl. 1:80-80(2002)

PubMed=12359050; DOI=10.1111/j.1349-7006.2002.tb02473.x; PMCID=PMC5927136
Bar J.K., Harlozinska-Szmyrka A.U., Kartarius S., Montenarh M., Wyrodek E., Rodriguez-Parkitna J.M., Kochman M., Ozyhar A.
Temperature-sensitive ovarian carcinoma cell line (OvBH-1).
Jpn. J. Cancer Res. 93:976-985(2002)

PubMed=16364757; DOI=10.1016/j.cancergencyto.2005.04.011
Schlade-Bartusiak K., Sasiadek M.M., Bar J.K., Urbschat S., Blin N., Montenarh M., Harlozinska-Szmyrka A.U.
Cytogenetic and molecular cytogenetic characterization of the stable ovarian carcinoma cell line (OvBH-1).
Cancer Genet. Cytogenet. 164:10-15(2006)

PubMed=26925792; DOI=10.4149/315_150930N510
Saczko J., Pilat J., Choromanska A., Rembialkowska N., Bar J.K., Deszcz I., Zalewski J., Kulbacka J.
The effectiveness of chemotherapy and electrochemotherapy on ovarian cell lines in vitro.
Neoplasma 63:450-455(2016)